EPISODE · Nov 14, 2022 · 13 MIN
DMTs Linked to Cervical Lesion Risk & Tecfidera Lowers Risk of 1st Symptoms in RIS
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article reporting on how exposure to high-efficacy DMTs is linked to an increased risk of cervical abnormalities in women with MS.He also reads another news article on Tecfidera reducing the risk of experiencing the first MS symptoms in adults with radiologically isolated syndrome.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
Embed this episode
NOW PLAYING
DMTs Linked to Cervical Lesion Risk & Tecfidera Lowers Risk of 1st Symptoms in RIS
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.